These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment. Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938 [No Abstract] [Full Text] [Related]
5. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Proclemer A; Ghidina M J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096 [No Abstract] [Full Text] [Related]
6. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death]. Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768 [TBL] [Abstract][Full Text] [Related]
7. New approach to implantable cardioverter-defibrillators in small pediatric patients: dorsal positioning of superior vena cava shock lead in a 3-year-old. Pedersen SB; Smerup MH; Nielsen JC J Thorac Cardiovasc Surg; 2014 Jul; 148(1):358-60. PubMed ID: 24685380 [No Abstract] [Full Text] [Related]
8. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing. Payne JE; Badertscher P; Field ME; Sturdivant JL; Gold MR Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008631. PubMed ID: 32703008 [No Abstract] [Full Text] [Related]
9. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients. Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928 [TBL] [Abstract][Full Text] [Related]
10. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation. Kuck KH Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082 [No Abstract] [Full Text] [Related]
11. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500 [No Abstract] [Full Text] [Related]
12. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications. Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093 [TBL] [Abstract][Full Text] [Related]
13. Antitachycardia pacing therapy for the successful treatment of lead fracture. Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719 [No Abstract] [Full Text] [Related]
14. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. Skowasch D; Ringquist S; Nickenig G; Andrié R PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033 [TBL] [Abstract][Full Text] [Related]
15. Seventh try's a charm: ventricular fibrillation terminated by the seventh shock. Li J; Zitron E; Katus HA; Becker R Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):e4-6. PubMed ID: 21505170 [No Abstract] [Full Text] [Related]
16. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery. Schloss EJ; Krebs ME; Gupta M Heart Rhythm; 2014 Oct; 11(10):1733-4. PubMed ID: 24931635 [No Abstract] [Full Text] [Related]
18. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation. Russo AM; Chung MK Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423 [No Abstract] [Full Text] [Related]
19. Underdetection of Ventricular Fibrillation by Wearable Cardioverter-Defibrillator Leading to Sudden Death. Kokubun H; Miyauchi Y; Inada S; Shimizu W Circ J; 2020 Dec; 85(1):79. PubMed ID: 33208580 [No Abstract] [Full Text] [Related]
20. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study. Farré J; Cabrera JA; Romero J; Rubio JM Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]